KrusegrAend 42D
Malmö 212 25
Sweden
46 7 38 14 52 15
https://www.duearity.com
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Fredrik Westman | CEO & MD | 885k | N/A | 1972 |
Mr. Gunnar Telhammar | Chief Financial Officer | N/A | N/A | 1961 |
Arash Golshenas | Chief Technology Officer | N/A | N/A | 1984 |
Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help people predict the symptoms and manage their problems. The company was incorporated in 2020 and is based in Malmö, Sweden.
Duearity AB (publ)s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.